Immunovant, Inc. (IMVT) NASDAQ
$29.26 0.40 (1.39%)
Market Cap: $4.28B
As of 09/13/24 10:59 AM EDT. Market open.
Immunovant, Inc. (IMVT)
NASDAQ
$29.26
0.40 (1.39%)
Market Cap: $4.28B
As of 09/13/24 10:59 AM EDT. Market open.
Add to Portfolio
Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of myasthenia gravis and thyroid eye disease, as well as ... read more
COMPANY PROFILE
Sector
Healthcare
Industry
Biotechnology
CEO
Dr. Peter Salzmann M.B.A., M.D.
Full Time Employees
207
CEO Compensation (Base)
$700,000
CEO Compensation (Total)
$8.55M
Sector
Healthcare
Industry
Biotechnology
CEO
Dr. Peter Salzmann M.B.A., M.D.
Full Time Employees
207
CEO Compensation (Base)
$700,000
CEO Compensation (Total)
$8.55M
Address
320 West 37th Street, NY, New York, 10018.
PRICE CHART FOR IMMUNOVANT, INC.
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$29.15
Previous Close
$28.86
Days Range
$29.06 - $29.58
52 week range
$19.50 - $45.58
Volume
202,661
Avg. Volume (30 days)
1,045,885
Market Cap
$4.28B
Dividend Yield
-
P/E
(15.32)
Shares Outstanding
146,367,000
Open
$29.15
Previous Close
$28.86
Days Range
$29.06 - $29.58
52 week range
$19.50 - $45.58
Volume
202,661
Avg. Volume (30 days)
1,045,885
Market Cap
$4.28B
Dividend Yield
-
P/E
(15.32)
Shares Outstanding
146,367,000
FINANCIAL STATEMENTS FOR IMMUNOVANT, INC.
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR IMMUNOVANT, INC.
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Levine Mark S. | Chief Legal Officer | Aug 21, 2024 | Sale | $31.86 | 3,295 | 104,976 | 330,230 | Aug 23, 2024, 04:15 PM |
| Macias William L. | Chief Medical Officer | Aug 21, 2024 | Sale | $31.86 | 3,027 | 96,437 | 368,452 | Aug 23, 2024, 04:14 PM |
| Barnett Eva Renee | Chief Financial Officer | Aug 21, 2024 | Sale | $31.86 | 3,768 | 120,045 | 343,925 | Aug 23, 2024, 04:11 PM |
| Butchko Julia G. | Chief Development Officer | Aug 21, 2024 | Sale | $31.86 | 3,027 | 96,437 | 441,079 | Aug 23, 2024, 04:10 PM |
| Salzmann Peter | Chief Executive Officer | Aug 21, 2024 | Sale | $31.86 | 15,068 | 480,052 | 1,008,942 | Aug 23, 2024, 04:07 PM |
| Stout Jay S | Chief Technology Officer | Jul 24, 2024 | Sale | $27.76 | 2,813 | 78,089 | 144,926 | Jul 26, 2024, 04:20 PM |
| Geffner Michael | Chief Medical Officer | Jul 24, 2024 | Sale | $27.76 | 3,456 | 95,939 | 138,160 | Jul 26, 2024, 04:19 PM |
| Levine Mark S. | Chief Legal Officer | Jul 24, 2024 | Sale | $27.76 | 4,015 | 111,456 | 333,394 | Jul 26, 2024, 04:17 PM |
| Levine Mark S. | Chief Legal Officer | Jul 17, 2024 | Sale | $29.69 | 2,505 | 74,382 | 337,556 | Jul 19, 2024, 05:42 PM |
| Macias William L. | Chief Medical Officer | Jul 17, 2024 | Sale | $29.69 | 3,044 | 90,386 | 372,041 | Jul 19, 2024, 05:41 PM |
| Barnett Eva Renee | Chief Financial Officer | Jul 17, 2024 | Sale | $29.69 | 3,123 | 92,733 | 347,728 | Jul 19, 2024, 05:39 PM |
| Butchko Julia G. | Chief Development Officer | Jul 17, 2024 | Sale | $29.69 | 2,867 | 85,132 | 444,155 | Jul 19, 2024, 05:38 PM |
| Salzmann Peter | Chief Executive Officer | Jul 17, 2024 | Sale | $29.69 | 8,685 | 257,887 | 1,023,922 | Jul 19, 2024, 05:36 PM |
| Barnett Eva Renee | Chief Financial Officer | Jul 09, 2024 | Sale | $28.06 | 4,747 | 133,201 | 350,667 | Jul 10, 2024, 05:07 PM |
| Butchko Julia G. | Chief Development Officer | Jul 09, 2024 | Sale | $28.06 | 1,527 | 42,848 | 446,853 | Jul 10, 2024, 05:06 PM |
| Salzmann Peter | Chief Executive Officer | Jul 09, 2024 | Sale | $28.06 | 4,619 | 129,609 | 1,032,097 | Jul 10, 2024, 05:04 PM |
| Barnett Eva Renee | Chief Financial Officer | May 22, 2024 | Sale | $29.65 | 4,042 | 119,845 | 355,414 | May 24, 2024, 04:18 PM |
| Salzmann Peter | Chief Executive Officer | May 22, 2024 | Sale | $29.65 | 16,163 | 479,233 | 1,036,716 | May 24, 2024, 04:15 PM |
| Butchko Julia G. | Chief Development Officer | May 22, 2024 | Sale | $29.65 | 3,247 | 96,274 | 448,380 | May 24, 2024, 04:14 PM |
| Macias William L. | Chief Medical Officer | May 22, 2024 | Sale | $29.65 | 3,247 | 96,274 | 374,403 | May 24, 2024, 04:13 PM |
| Levine Mark S. | Chief Legal Officer | May 22, 2024 | Sale | $29.65 | 3,242 | 96,125 | 339,914 | May 24, 2024, 04:10 PM |
| Geffner Michael | Chief Medical Officer | Apr 24, 2024 | Sale | $28.90 | 3,261 | 94,243 | 141,616 | Apr 26, 2024, 05:22 PM |
| Stout Jay S | Chief Technology Officer | Apr 24, 2024 | Sale | $28.90 | 7,239 | 209,207 | 147,739 | Apr 26, 2024, 05:20 PM |
| Levine Mark S. | Chief Legal Officer | Apr 24, 2024 | Sale | $28.90 | 3,963 | 114,531 | 343,156 | Apr 26, 2024, 05:18 PM |
| Levine Mark S. | Chief Legal Officer | Apr 17, 2024 | Sale | $29.06 | 9,827 | 285,554 | 349,344 | Apr 19, 2024, 06:06 PM |
| Macias William L. | Chief Medical Officer | Apr 17, 2024 | Sale | $29.06 | 8,280 | 240,601 | 379,794 | Apr 19, 2024, 06:05 PM |
| Barnett Eva Renee | Chief Financial Officer | Apr 17, 2024 | Sale | $29.06 | 12,253 | 356,049 | 362,230 | Apr 19, 2024, 06:01 PM |
| Butchko Julia G. | Chief Development Officer | Apr 17, 2024 | Sale | $29.06 | 10,115 | 293,923 | 453,917 | Apr 19, 2024, 05:59 PM |
| Salzmann Peter | Chief Executive Officer | Apr 17, 2024 | Sale | $29.06 | 34,079 | 990,269 | 1,060,593 | Apr 19, 2024, 05:57 PM |
| Barnett Eva Renee | Chief Financial Officer | Apr 09, 2024 | Sale | $31.18 | 3,689 | 115,023 | 371,709 | Apr 10, 2024, 04:18 PM |
| Butchko Julia G. | Chief Development Officer | Apr 09, 2024 | Sale | $31.18 | 1,053 | 32,833 | 461,742 | Apr 10, 2024, 04:16 PM |
| Salzmann Peter | Chief Executive Officer | Apr 09, 2024 | Sale | $31.18 | 4,807 | 149,882 | 1,086,958 | Apr 10, 2024, 04:14 PM |
| Barnett Eva Renee | Chief Financial Officer | Feb 22, 2024 | Sale | $36.15 | 2,930 | 105,920 | 320,420 | Feb 23, 2024, 04:21 PM |
| Levine Mark S. | Chief Legal Officer | Feb 22, 2024 | Sale | $36.15 | 2,134 | 77,144 | 301,968 | Feb 23, 2024, 04:18 PM |
| Macias William L. | Chief Medical Officer | Feb 22, 2024 | Sale | $36.15 | 2,221 | 80,289 | 330,952 | Feb 23, 2024, 04:16 PM |
| Butchko Julia G. | Chief Development Officer | Feb 22, 2024 | Sale | $36.15 | 2,146 | 77,578 | 407,817 | Feb 23, 2024, 04:14 PM |
| Salzmann Peter | Chief Executive Officer | Feb 22, 2024 | Sale | $36.15 | 13,454 | 486,362 | 931,231 | Feb 23, 2024, 04:11 PM |
| Levine Mark S. | Chief Legal Officer | Jan 26, 2024 | Sale | $37.92 | 3,027 | 114,778 | 304,148 | Jan 29, 2024, 04:12 PM |
| Geffner Michael | Chief Medical Officer | Jan 26, 2024 | Sale | $37.92 | 10,101 | 383,012 | 90,052 | Jan 29, 2024, 04:11 PM |
| Macias William L. | Chief Medical Officer | Jan 18, 2024 | Sale | $41.03 | 424 | 17,397 | 333,173 | Jan 19, 2024, 04:04 PM |
| Barnett Eva Renee | Chief Financial Officer | Jan 11, 2024 | Sale | $41.83 | 3,515 | 147,023 | 324,184 | Jan 12, 2024, 04:34 PM |
| Butchko Julia G. | Chief Development Officer | Jan 05, 2024 | Sale | $38.59 | 1,297 | 50,051 | 409,963 | Jan 09, 2024, 04:20 PM |
| Salzmann Peter | Chief Executive Officer | Jan 05, 2024 | Sale | $38.59 | 3,824 | 147,568 | 944,685 | Jan 09, 2024, 04:18 PM |
| Fromkin Andrew J. | Director | Dec 01, 2023 | Sale | $39.73 | 12,350 | 490,697 | 97,067 | Dec 05, 2023, 04:30 PM |
| Pande Atul | Director | Dec 01, 2023 | Sale | $39.73 | 12,350 | 490,667 | 91,379 | Dec 05, 2023, 04:28 PM |
| MIGAUSKY GEORGE V | Director | Dec 01, 2023 | Sale | $39.73 | 12,700 | 504,567 | 118,308 | Dec 05, 2023, 04:25 PM |
| Salzmann Peter | Chief Executive Officer | Nov 22, 2023 | Sale | $32.78 | 16,217 | 531,581 | 949,125 | Nov 24, 2023, 02:55 PM |
| Barnett Eva Renee | Chief Financial Officer | Nov 22, 2023 | Sale | $32.78 | 4,055 | 132,920 | 327,019 | Nov 24, 2023, 02:51 PM |
| Butchko Julia G. | Chief Development Officer | Nov 22, 2023 | Sale | $32.78 | 3,265 | 107,024 | 411,384 | Nov 24, 2023, 02:47 PM |
| Macias William L. | Chief Medical Officer | Nov 22, 2023 | Sale | $32.78 | 3,265 | 107,024 | 333,721 | Nov 24, 2023, 02:45 PM |
| Levine Mark S. | Chief Legal Officer | Nov 22, 2023 | Sale | $32.78 | 3,252 | 106,598 | 307,253 | Nov 24, 2023, 02:41 PM |
| Levine Mark S. | Chief Legal Officer | Oct 25, 2023 | Sale | $34.66 | 4,107 | 142,349 | 310,381 | Oct 27, 2023, 04:04 PM |
| Macias William L. | Chief Medical Officer | Oct 19, 2023 | Sale | $36.80 | 530 | 19,504 | 336,862 | Oct 20, 2023, 04:06 PM |
| Barnett Eva Renee | Chief Financial Officer | Oct 10, 2023 | Sale | $36.92 | 4,557 | 168,244 | 330,920 | Oct 11, 2023, 04:11 PM |
| Butchko Julia G. | Chief Development Officer | Oct 05, 2023 | Sale | $36.24 | 1,735 | 62,885 | 415,964 | Oct 06, 2023, 05:15 PM |
| Salzmann Peter | Chief Executive Officer | Oct 05, 2023 | Sale | $36.24 | 5,239 | 189,887 | 969,071 | Oct 06, 2023, 05:10 PM |
| Roivant Sciences Ltd. | Director | Oct 02, 2023 | Option Exercise | $38.00 | 4,473,684 | 169,999,992 | 78,279,015 | Oct 04, 2023, 05:15 PM |
| Roivant Sciences Ltd. | Director | Oct 02, 2023 | Buy | $38.00 | 1,526,316 | 58,000,008 | 79,805,331 | Oct 04, 2023, 05:15 PM |
| Salzmann Peter | Chief Executive Officer | Aug 30, 2023 | Sale | $22.02 | 56,774 | 1,250,338 | 975,873 | Sep 01, 2023, 04:08 PM |
| Levine Mark S. | Chief Legal Officer | Aug 24, 2023 | Sale | $20.30 | 12,286 | 249,406 | 314,489 | Aug 25, 2023, 05:05 PM |
| Barnett Eva Renee | Chief Financial Officer | Aug 24, 2023 | Sale | $20.30 | 14,386 | 292,036 | 335,478 | Aug 25, 2023, 05:03 PM |
| Butchko Julia G. | Chief Development Officer | Aug 24, 2023 | Sale | $20.30 | 12,333 | 250,360 | 416,261 | Aug 25, 2023, 05:00 PM |
| Macias William L. | Chief Medical Officer | Aug 24, 2023 | Sale | $20.30 | 12,333 | 250,360 | 337,393 | Aug 25, 2023, 04:57 PM |
| Salzmann Peter | Chief Executive Officer | Aug 14, 2023 | Sale | $21.42 | 103,058 | 2,207,178 | 1,038,053 | Aug 16, 2023, 04:11 PM |
| Salzmann Peter | Chief Executive Officer | Aug 07, 2023 | Sale | $21.73 | 101,339 | 2,202,096 | 1,129,797 | Aug 08, 2023, 04:44 PM |
| Levine Mark S. | Chief Legal Officer | Jul 26, 2023 | Sale | $21.63 | 3,917 | 84,725 | 326,774 | Jul 27, 2023, 04:33 PM |
| Macias William L. | Chief Medical Officer | Jul 19, 2023 | Sale | $24.94 | 426 | 10,624 | 349,725 | Jul 20, 2023, 04:37 PM |
| Barnett Eva Renee | Chief Financial Officer | Jul 19, 2023 | Sale | $24.94 | 2,725 | 67,962 | 349,863 | Jul 20, 2023, 04:35 PM |
| Salzmann Peter | Chief Executive Officer | Jul 12, 2023 | Sale | $19.73 | 3,233 | 63,787 | 1,231,136 | Jul 13, 2023, 05:11 PM |
| Butchko Julia G. | Chief Development Officer | Jul 12, 2023 | Sale | $19.73 | 1,470 | 29,003 | 428,593 | Jul 13, 2023, 05:10 PM |
| Macias William L. | Chief Medical Officer | Apr 25, 2023 | Sale | $16.29 | 509 | 8,292 | 350,151 | Apr 26, 2023, 04:12 PM |
| Levine Mark S. | Chief Legal Officer | Apr 25, 2023 | Sale | $16.29 | 2,633 | 42,892 | 330,691 | Apr 26, 2023, 04:08 PM |
| Barnett Eva Renee | Chief Financial Officer | Apr 18, 2023 | Sale | $15.27 | 3,423 | 52,269 | 352,588 | Apr 19, 2023, 04:15 PM |
| Butchko Julia G. | Chief Development Officer | Apr 18, 2023 | Sale | $15.27 | 1,544 | 23,577 | 430,063 | Apr 19, 2023, 04:12 PM |
| Salzmann Peter | Chief Executive Officer | Apr 18, 2023 | Sale | $15.27 | 3,395 | 51,842 | 1,234,369 | Apr 19, 2023, 04:09 PM |
| Macias William L. | Chief Medical Officer | Feb 02, 2023 | Sale | $18.24 | 537 | 9,795 | 262,996 | Feb 03, 2023, 07:24 AM |
| Levine Mark S. | Chief Legal Officer | Jan 26, 2023 | Sale | $18.51 | 10,156 | 187,988 | 245,660 | Jan 27, 2023, 07:20 AM |
| Salzmann Peter | Chief Executive Officer | Jan 11, 2023 | Sale | $16.80 | 4,021 | 67,553 | 993,932 | Jan 13, 2023, 08:21 AM |
| Butchko Julia G. | Chief Dev. & Tech. Officer | Jan 11, 2023 | Sale | $16.79 | 60,490 | 1,015,596 | 391,890 | Jan 13, 2023, 08:19 AM |
| Barnett Eva Renee | Chief Financial Officer | Jan 11, 2023 | Sale | $16.75 | 4,510 | 75,525 | 272,846 | Jan 13, 2023, 08:16 AM |
| Macias William L. | Chief Medical Officer | Jan 11, 2023 | Sale | $16.75 | 44,568 | 746,317 | 307,981 | Jan 13, 2023, 08:13 AM |
| Macias William L. | Chief Medical Officer | Oct 21, 2022 | Sale | $9.67 | 341 | 3,297 | 308,101 | Oct 25, 2022, 07:43 AM |
| Butchko Julia G. | Chief Dev. & Tech. Officer | Oct 13, 2022 | Sale | $9.18 | 928 | 8,519 | 391,909 | Oct 17, 2022, 08:59 AM |
| Salzmann Peter | Chief Executive Officer | Oct 13, 2022 | Sale | $9.18 | 2,793 | 25,640 | 997,953 | Oct 17, 2022, 08:57 AM |
| Barnett Eva Renee | Chief Financial Officer | Oct 11, 2022 | Sale | $9.44 | 12,500 | 118,000 | 272,857 | Oct 13, 2022, 04:20 PM |
| Roivant Sciences Ltd. | 10% Owner | Oct 06, 2022 | Buy | $6.00 | 416,667 | 2,500,002 | 73,805,331 | Oct 07, 2022, 04:32 PM |
| Butchko Julia G. | Chief Dev. & Tech. Officer | Sep 28, 2022 | Sale | $4.67 | 535 | 2,498 | 392,837 | Sep 29, 2022, 05:09 PM |
| Salzmann Peter | Chief Executive Officer | Sep 28, 2022 | Sale | $4.67 | 1,605 | 7,495 | 1,000,746 | Sep 29, 2022, 05:06 PM |
| Torti Frank | Director | Sep 29, 2022 | Buy | $5.81 | 20,000 | 116,200 | 393,358 | Sep 29, 2022, 04:21 PM |
| Salzmann Peter | Chief Executive Officer | Aug 30, 2022 | Sale | $5.83 | 1,644 | 9,585 | 1,002,351 | Sep 01, 2022, 07:36 AM |
| Butchko Julia G. | Chief Dev. & Tech. Officer | Aug 30, 2022 | Sale | $5.83 | 548 | 3,195 | 393,372 | Sep 01, 2022, 07:33 AM |
| Butchko Julia G. | Chief Dev. & Tech. Officer | Jul 27, 2022 | Sale | $4.27 | 510 | 2,178 | 281,104 | Jul 29, 2022, 07:38 AM |
| Salzmann Peter | Chief Executive Officer | Jul 27, 2022 | Sale | $4.27 | 1,528 | 6,525 | 552,731 | Jul 29, 2022, 07:36 AM |
| Macias William L. | Chief Medical Officer | Jul 22, 2022 | Sale | $4.70 | 322 | 1,513 | 195,626 | Jul 26, 2022, 07:35 AM |
| Salzmann Peter | Chief Executive Officer | Jun 29, 2022 | Sale | $4.02 | 1,376 | 5,532 | 554,259 | Jul 01, 2022, 07:05 AM |
| Butchko Julia G. | Chief Dev. & Tech. Officer | Jun 29, 2022 | Sale | $4.02 | 460 | 1,849 | 281,614 | Jul 01, 2022, 07:04 AM |
| Butchko Julia G. | Chief Dev. & Tech. Officer | May 24, 2022 | Sale | $3.79 | 492 | 1,865 | 282,074 | May 25, 2022, 04:26 PM |
| Salzmann Peter | Chief Executive Officer | May 24, 2022 | Sale | $3.79 | 1,471 | 5,575 | 555,635 | May 25, 2022, 04:23 PM |
| Butchko Julia G. | Chief Dev. & Tech. Officer | Apr 27, 2022 | Sale | $4.72 | 541 | 2,554 | 282,566 | Apr 29, 2022, 07:08 AM |
| Salzmann Peter | Chief Executive Officer | Apr 27, 2022 | Sale | $4.72 | 1,622 | 7,656 | 557,106 | Apr 29, 2022, 07:05 AM |
| Macias William L. | Chief Medical Officer | Apr 19, 2022 | Sale | $4.98 | 1,392 | 6,932 | 195,948 | Apr 20, 2022, 04:34 PM |
| Butchko Julia G. | Chief Dev. & Tech. Officer | Mar 24, 2022 | Sale | $5.90 | 6,381 | 37,648 | 283,107 | Apr 14, 2022, 07:18 AM |
| Salzmann Peter | Chief Executive Officer | Mar 24, 2022 | Sale | $5.90 | 19,227 | 113,439 | 558,728 | Apr 14, 2022, 07:16 AM |
| Butchko Julia G. | Chief Dev. & Tech. Officer | Jan 07, 2022 | Sale | $7.25 | 55,318 | 401,056 | 289,488 | Jan 11, 2022, 10:58 AM |
| Barnett Eva Renee | Chief Financial Officer | Jan 07, 2022 | Sale | $7.25 | 29,959 | 217,203 | 172,541 | Jan 11, 2022, 10:53 AM |
| Salzmann Peter | Chief Executive Officer | Jan 07, 2022 | Sale | $7.25 | 125,158 | 907,396 | 577,955 | Jan 11, 2022, 10:49 AM |
| Macias William L. | Chief Medical Officer | Jan 05, 2022 | Sale | $8.28 | 26,813 | 222,012 | 197,340 | Jan 07, 2022, 12:39 PM |
| Hughes Douglas J. | Director | Aug 27, 2021 | Buy | $8.24 | 18,247 | 150,355 | 58,447 | Aug 30, 2021, 09:08 AM |
| MIGAUSKY GEORGE V | Director | Aug 20, 2021 | Buy | $7.65 | 7,000 | 53,550 | 67,200 | Aug 20, 2021, 06:14 PM |
| Pande Atul | Director | Aug 13, 2021 | Buy | $7.98 | 5,000 | 39,900 | 45,200 | Aug 16, 2021, 05:29 PM |
| Fromkin Andrew J. | Director | Aug 10, 2021 | Buy | $7.90 | 5,500 | 43,450 | 45,700 | Aug 11, 2021, 02:12 PM |
| Butchko Julia G. | Chief Dev. & Tech. Officer | Sep 11, 2020 | Buy | $38.17 | 5,000 | 190,850 | 5,000 | Sep 15, 2020, 05:09 PM |
| Roivant Sciences Ltd. | 10% Owner | Sep 04, 2020 | Buy | $33.00 | 380,000 | 12,540,000 | 47,593,419 | Sep 04, 2020, 05:29 PM |
| Roivant Sciences Ltd. | 10% Owner | Apr 16, 2020 | Buy | $14.50 | 1,034,483 | 15,000,004 | 38,439,450 | Apr 17, 2020, 05:28 PM |
| Roivant Sciences Ltd. | 10% Owner | Dec 18, 2019 | Option Exercise | $10.00 | 36,919,967 | 369,199,670 | 37,404,967 | Dec 20, 2019, 05:28 PM |
| WONG RODERICK | Chief Executive Officer | Dec 11, 2019 | Buy | $10.92 | 31,500 | 344,024 | 902,498 | Dec 13, 2019, 06:00 PM |
| WONG RODERICK | Chief Executive Officer | Dec 10, 2019 | Buy | $10.38 | 25,971 | 269,517 | 870,998 | Dec 10, 2019, 06:22 PM |
| WONG RODERICK | Chief Executive Officer | Dec 06, 2019 | Buy | $10.20 | 50,000 | 510,125 | 845,027 | Dec 09, 2019, 05:01 PM |
| WONG RODERICK | Chief Executive Officer | Dec 06, 2019 | Buy | $10.25 | 400,000 | 4,100,000 | 795,027 | Dec 09, 2019, 07:31 AM |
| WONG RODERICK | Chief Executive Officer | Dec 05, 2019 | Buy | $10.15 | 20,000 | 203,000 | 395,027 | Dec 05, 2019, 06:07 PM |
| WONG RODERICK | Chief Executive Officer | Dec 04, 2019 | Buy | $10.15 | 20,000 | 203,000 | 375,027 | Dec 04, 2019, 06:33 PM |
| WONG RODERICK | Chief Executive Officer | Dec 03, 2019 | Buy | $10.21 | 20,000 | 204,200 | 355,027 | Dec 03, 2019, 05:42 PM |
| WONG RODERICK | Chief Executive Officer | Dec 02, 2019 | Buy | $10.40 | 20,000 | 208,000 | 335,027 | Dec 03, 2019, 05:42 PM |
| WONG RODERICK | Chief Executive Officer | Nov 29, 2019 | Buy | $10.45 | 26,918 | 281,293 | 315,027 | Dec 03, 2019, 05:42 PM |
| WONG RODERICK | Chief Executive Officer | Nov 27, 2019 | Buy | $10.48 | 4,000 | 41,904 | 288,109 | Nov 29, 2019, 01:00 PM |
| WONG RODERICK | Chief Executive Officer | Nov 26, 2019 | Buy | $10.49 | 4,000 | 41,960 | 284,109 | Nov 29, 2019, 01:00 PM |
| WONG RODERICK | Chief Executive Officer | Nov 25, 2019 | Buy | $10.50 | 4,000 | 42,000 | 280,109 | Nov 29, 2019, 01:00 PM |
| WONG RODERICK | Chief Executive Officer | Nov 22, 2019 | Buy | $10.54 | 2,000 | 21,080 | 276,109 | Nov 22, 2019, 05:42 PM |
| WONG RODERICK | Chief Executive Officer | Nov 21, 2019 | Buy | $10.42 | 15,194 | 158,299 | 274,109 | Nov 22, 2019, 05:42 PM |
| WONG RODERICK | Chief Executive Officer | Nov 20, 2019 | Buy | $10.39 | 29,805 | 309,582 | 258,915 | Nov 22, 2019, 05:42 PM |
| WONG RODERICK | Chief Executive Officer | Nov 19, 2019 | Buy | $10.25 | 29,805 | 305,501 | 229,110 | Nov 19, 2019, 06:06 PM |
| WONG RODERICK | Chief Executive Officer | Nov 18, 2019 | Buy | $10.25 | 29,805 | 305,501 | 199,305 | Nov 19, 2019, 06:06 PM |
| WONG RODERICK | Chief Executive Officer | Nov 15, 2019 | Buy | $10.29 | 13,000 | 133,800 | 169,500 | Nov 19, 2019, 06:06 PM |
| WONG RODERICK | Chief Executive Officer | Nov 13, 2019 | Buy | $10.17 | 13,000 | 132,210 | 143,500 | Nov 14, 2019, 05:51 PM |
| WONG RODERICK | Chief Executive Officer | Nov 12, 2019 | Buy | $10.17 | 100,000 | 1,017,000 | 130,500 | Nov 14, 2019, 05:51 PM |
| WONG RODERICK | Chief Executive Officer | Nov 14, 2019 | Buy | $10.17 | 13,000 | 132,210 | 156,500 | Nov 14, 2019, 05:51 PM |
| WONG RODERICK | Chief Executive Officer | Nov 11, 2019 | Buy | $10.18 | 13,000 | 132,340 | 30,500 | Nov 12, 2019, 06:59 AM |
| WONG RODERICK | Chief Executive Officer | Nov 07, 2019 | Buy | $10.18 | 17,500 | 178,150 | 17,500 | Nov 12, 2019, 06:59 AM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Levine Mark S. | Chief Legal Officer | 08/21/2024 | 104,976 |
| Macias William L. | Chief Medical Officer | 08/21/2024 | 96,437 |
| Barnett Eva Renee | Chief Financial Officer | 08/21/2024 | 120,045 |
| Butchko Julia G. | Chief Development Officer | 08/21/2024 | 96,437 |
| Salzmann Peter | Chief Executive Officer | 08/21/2024 | 480,052 |
| Stout Jay S | Chief Technology Officer | 07/24/2024 | 78,089 |
| Geffner Michael | Chief Medical Officer | 07/24/2024 | 95,939 |
| Levine Mark S. | Chief Legal Officer | 07/24/2024 | 111,456 |
| Levine Mark S. | Chief Legal Officer | 07/17/2024 | 74,382 |
| Macias William L. | Chief Medical Officer | 07/17/2024 | 90,386 |
| Barnett Eva Renee | Chief Financial Officer | 07/17/2024 | 92,733 |
| Butchko Julia G. | Chief Development Officer | 07/17/2024 | 85,132 |
| Salzmann Peter | Chief Executive Officer | 07/17/2024 | 257,887 |
| Barnett Eva Renee | Chief Financial Officer | 07/09/2024 | 133,201 |
| Butchko Julia G. | Chief Development Officer | 07/09/2024 | 42,848 |
| Salzmann Peter | Chief Executive Officer | 07/09/2024 | 129,609 |
| Barnett Eva Renee | Chief Financial Officer | 05/22/2024 | 119,845 |
| Salzmann Peter | Chief Executive Officer | 05/22/2024 | 479,233 |
| Butchko Julia G. | Chief Development Officer | 05/22/2024 | 96,274 |
| Macias William L. | Chief Medical Officer | 05/22/2024 | 96,274 |
| Levine Mark S. | Chief Legal Officer | 05/22/2024 | 96,125 |
| Geffner Michael | Chief Medical Officer | 04/24/2024 | 94,243 |
| Stout Jay S | Chief Technology Officer | 04/24/2024 | 209,207 |
| Levine Mark S. | Chief Legal Officer | 04/24/2024 | 114,531 |
| Levine Mark S. | Chief Legal Officer | 04/17/2024 | 285,554 |
| Macias William L. | Chief Medical Officer | 04/17/2024 | 240,601 |
| Barnett Eva Renee | Chief Financial Officer | 04/17/2024 | 356,049 |
| Butchko Julia G. | Chief Development Officer | 04/17/2024 | 293,923 |
| Salzmann Peter | Chief Executive Officer | 04/17/2024 | 990,269 |
| Barnett Eva Renee | Chief Financial Officer | 04/09/2024 | 115,023 |
| Butchko Julia G. | Chief Development Officer | 04/09/2024 | 32,833 |
| Salzmann Peter | Chief Executive Officer | 04/09/2024 | 149,882 |
| Barnett Eva Renee | Chief Financial Officer | 02/22/2024 | 105,920 |
| Levine Mark S. | Chief Legal Officer | 02/22/2024 | 77,144 |
| Macias William L. | Chief Medical Officer | 02/22/2024 | 80,289 |
| Butchko Julia G. | Chief Development Officer | 02/22/2024 | 77,578 |
| Salzmann Peter | Chief Executive Officer | 02/22/2024 | 486,362 |
| Levine Mark S. | Chief Legal Officer | 01/26/2024 | 114,778 |
| Geffner Michael | Chief Medical Officer | 01/26/2024 | 383,012 |
| Macias William L. | Chief Medical Officer | 01/18/2024 | 17,397 |
| Barnett Eva Renee | Chief Financial Officer | 01/11/2024 | 147,023 |
| Butchko Julia G. | Chief Development Officer | 01/05/2024 | 50,051 |
| Salzmann Peter | Chief Executive Officer | 01/05/2024 | 147,568 |
| Fromkin Andrew J. | Director | 12/01/2023 | 490,697 |
| Pande Atul | Director | 12/01/2023 | 490,667 |
| MIGAUSKY GEORGE V | Director | 12/01/2023 | 504,567 |
| Salzmann Peter | Chief Executive Officer | 11/22/2023 | 531,581 |
| Barnett Eva Renee | Chief Financial Officer | 11/22/2023 | 132,920 |
| Butchko Julia G. | Chief Development Officer | 11/22/2023 | 107,024 |
| Macias William L. | Chief Medical Officer | 11/22/2023 | 107,024 |
| Levine Mark S. | Chief Legal Officer | 11/22/2023 | 106,598 |
| Levine Mark S. | Chief Legal Officer | 10/25/2023 | 142,349 |
| Macias William L. | Chief Medical Officer | 10/19/2023 | 19,504 |
| Barnett Eva Renee | Chief Financial Officer | 10/10/2023 | 168,244 |
| Butchko Julia G. | Chief Development Officer | 10/05/2023 | 62,885 |
| Salzmann Peter | Chief Executive Officer | 10/05/2023 | 189,887 |
| Roivant Sciences Ltd. | Director | 10/02/2023 | 169,999,992 |
| Roivant Sciences Ltd. | Director | 10/02/2023 | 58,000,008 |
| Salzmann Peter | Chief Executive Officer | 08/30/2023 | 1,250,338 |
| Levine Mark S. | Chief Legal Officer | 08/24/2023 | 249,406 |
| Barnett Eva Renee | Chief Financial Officer | 08/24/2023 | 292,036 |
| Butchko Julia G. | Chief Development Officer | 08/24/2023 | 250,360 |
| Macias William L. | Chief Medical Officer | 08/24/2023 | 250,360 |
| Salzmann Peter | Chief Executive Officer | 08/14/2023 | 2,207,178 |
| Salzmann Peter | Chief Executive Officer | 08/07/2023 | 2,202,096 |
| Levine Mark S. | Chief Legal Officer | 07/26/2023 | 84,725 |
| Macias William L. | Chief Medical Officer | 07/19/2023 | 10,624 |
| Barnett Eva Renee | Chief Financial Officer | 07/19/2023 | 67,962 |
| Salzmann Peter | Chief Executive Officer | 07/12/2023 | 63,787 |
| Butchko Julia G. | Chief Development Officer | 07/12/2023 | 29,003 |
| Macias William L. | Chief Medical Officer | 04/25/2023 | 8,292 |
| Levine Mark S. | Chief Legal Officer | 04/25/2023 | 42,892 |
| Barnett Eva Renee | Chief Financial Officer | 04/18/2023 | 52,269 |
| Butchko Julia G. | Chief Development Officer | 04/18/2023 | 23,577 |
| Salzmann Peter | Chief Executive Officer | 04/18/2023 | 51,842 |
| Macias William L. | Chief Medical Officer | 02/02/2023 | 9,795 |
| Levine Mark S. | Chief Legal Officer | 01/26/2023 | 187,988 |
| Salzmann Peter | Chief Executive Officer | 01/11/2023 | 67,553 |
| Butchko Julia G. | Chief Dev. & Tech. Officer | 01/11/2023 | 1,015,596 |
| Barnett Eva Renee | Chief Financial Officer | 01/11/2023 | 75,525 |
| Macias William L. | Chief Medical Officer | 01/11/2023 | 746,317 |
| Macias William L. | Chief Medical Officer | 10/21/2022 | 3,297 |
| Butchko Julia G. | Chief Dev. & Tech. Officer | 10/13/2022 | 8,519 |
| Salzmann Peter | Chief Executive Officer | 10/13/2022 | 25,640 |
| Barnett Eva Renee | Chief Financial Officer | 10/11/2022 | 118,000 |
| Roivant Sciences Ltd. | 10% Owner | 10/06/2022 | 2,500,002 |
| Butchko Julia G. | Chief Dev. & Tech. Officer | 09/28/2022 | 2,498 |
| Salzmann Peter | Chief Executive Officer | 09/28/2022 | 7,495 |
| Torti Frank | Director | 09/29/2022 | 116,200 |
| Salzmann Peter | Chief Executive Officer | 08/30/2022 | 9,585 |
| Butchko Julia G. | Chief Dev. & Tech. Officer | 08/30/2022 | 3,195 |
| Butchko Julia G. | Chief Dev. & Tech. Officer | 07/27/2022 | 2,178 |
| Salzmann Peter | Chief Executive Officer | 07/27/2022 | 6,525 |
| Macias William L. | Chief Medical Officer | 07/22/2022 | 1,513 |
| Salzmann Peter | Chief Executive Officer | 06/29/2022 | 5,532 |
| Butchko Julia G. | Chief Dev. & Tech. Officer | 06/29/2022 | 1,849 |
| Butchko Julia G. | Chief Dev. & Tech. Officer | 05/24/2022 | 1,865 |
| Salzmann Peter | Chief Executive Officer | 05/24/2022 | 5,575 |
| Butchko Julia G. | Chief Dev. & Tech. Officer | 04/27/2022 | 2,554 |
| Salzmann Peter | Chief Executive Officer | 04/27/2022 | 7,656 |
| Macias William L. | Chief Medical Officer | 04/19/2022 | 6,932 |
| Butchko Julia G. | Chief Dev. & Tech. Officer | 03/24/2022 | 37,648 |
| Salzmann Peter | Chief Executive Officer | 03/24/2022 | 113,439 |
| Butchko Julia G. | Chief Dev. & Tech. Officer | 01/07/2022 | 401,056 |
| Barnett Eva Renee | Chief Financial Officer | 01/07/2022 | 217,203 |
| Salzmann Peter | Chief Executive Officer | 01/07/2022 | 907,396 |
| Macias William L. | Chief Medical Officer | 01/05/2022 | 222,012 |
| Hughes Douglas J. | Director | 08/27/2021 | 150,355 |
| MIGAUSKY GEORGE V | Director | 08/20/2021 | 53,550 |
| Pande Atul | Director | 08/13/2021 | 39,900 |
| Fromkin Andrew J. | Director | 08/10/2021 | 43,450 |
| Butchko Julia G. | Chief Dev. & Tech. Officer | 09/11/2020 | 190,850 |
| Roivant Sciences Ltd. | 10% Owner | 09/04/2020 | 12,540,000 |
| Roivant Sciences Ltd. | 10% Owner | 04/16/2020 | 15,000,004 |
| Roivant Sciences Ltd. | 10% Owner | 12/18/2019 | 369,199,670 |
| WONG RODERICK | Chief Executive Officer | 12/11/2019 | 344,024 |
| WONG RODERICK | Chief Executive Officer | 12/10/2019 | 269,517 |
| WONG RODERICK | Chief Executive Officer | 12/06/2019 | 510,125 |
| WONG RODERICK | Chief Executive Officer | 12/06/2019 | 4,100,000 |
| WONG RODERICK | Chief Executive Officer | 12/05/2019 | 203,000 |
| WONG RODERICK | Chief Executive Officer | 12/04/2019 | 203,000 |
| WONG RODERICK | Chief Executive Officer | 12/03/2019 | 204,200 |
| WONG RODERICK | Chief Executive Officer | 12/02/2019 | 208,000 |
| WONG RODERICK | Chief Executive Officer | 11/29/2019 | 281,293 |
| WONG RODERICK | Chief Executive Officer | 11/27/2019 | 41,904 |
| WONG RODERICK | Chief Executive Officer | 11/26/2019 | 41,960 |
| WONG RODERICK | Chief Executive Officer | 11/25/2019 | 42,000 |
| WONG RODERICK | Chief Executive Officer | 11/22/2019 | 21,080 |
| WONG RODERICK | Chief Executive Officer | 11/21/2019 | 158,299 |
| WONG RODERICK | Chief Executive Officer | 11/20/2019 | 309,582 |
| WONG RODERICK | Chief Executive Officer | 11/19/2019 | 305,501 |
| WONG RODERICK | Chief Executive Officer | 11/18/2019 | 305,501 |
| WONG RODERICK | Chief Executive Officer | 11/15/2019 | 133,800 |
| WONG RODERICK | Chief Executive Officer | 11/13/2019 | 132,210 |
| WONG RODERICK | Chief Executive Officer | 11/12/2019 | 1,017,000 |
| WONG RODERICK | Chief Executive Officer | 11/14/2019 | 132,210 |
| WONG RODERICK | Chief Executive Officer | 11/11/2019 | 132,340 |
| WONG RODERICK | Chief Executive Officer | 11/07/2019 | 178,150 |
Load More Insider Transactions
FUNDS WITH A POSITION IN IMMUNOVANT, INC.
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| BLACKROCK INC. | 4,916,127 | 0.00294% | 9.81% | Other |
| ALPINE GLOBAL MANAGEMENT, LLC | 1,907,704 | 8.76% | -49.34% | Event Driven |
| VIKING GLOBAL INVESTORS LP | 2,320,902 | 0.24% | 28.29% | Growth At A Reasonable Price |
| GEODE CAPITAL MANAGEMENT, LLC | 1,414,002 | 0.00328% | 7.38% | Other |
| CAPITAL RESEARCH GLOBAL INVESTORS | 976,237 | 0.00566% | No change | Growth At A Reasonable Price |
| BAKER BROS. ADVISORS LP | 464,718 | 0.16% | 9.34% | Other |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 420,000 | 0.02% | 320% | Other |
| RENAISSANCE TECHNOLOGIES LLC | 388,100 | 0.02% | 14.25% | Other |
| SENATOR INVESTMENT GROUP LP | 250,000 | 0.32% | No change | Event Driven, Value |
| PLATINUM INVESTMENT MANAGEMENT LTD | 192,242 | 0.21% | 0.83% | Growth At A Reasonable Price, Value |
| WCM INVESTMENT MANAGEMENT, LLC | 175,542 | 0.01% | 3.46% | Growth At A Reasonable Price |
| ALPS ADVISORS INC | 113,931 | 0.02% | New | Other |
| AQR CAPITAL MANAGEMENT LLC | 86,283 | 0.00349% | -2.61% | Other |
| TUDOR INVESTMENT CORP ET AL | 87,397 | 0.02% | Exited | Event Driven, Other |
| BAMCO INC /NY/ | 55,000 | 0.00416% | -8.33% | Growth At A Reasonable Price |
| D. E. SHAW & CO., INC. | 41,479 | 0.00102% | -25.82% | Other |
| FARALLON CAPITAL MANAGEMENT LLC | 12,000 | 0.00149% | New | Event Driven, Value |
CHANGE IN SHARES OUTSTANDING FOR IMMUNOVANT, INC.
STOCK BUYBACKS FOR IMMUNOVANT, INC.
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 03/31/2024
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
12/31/2023
0.79%
1Q
09/30/2023
11.07%
2Q
06/30/2023
11.62%
3Q
03/31/2023
11.79%
4Q
12/31/2022
13.30%
5Q
09/30/2022
24.96%
6Q
06/30/2022
24.98%
7Q
03/31/2022
25.17%
8Q
12/31/2021
26.64%
9Q
09/30/2021
33.55%
10Q
06/30/2021
48.68%
11Q
03/31/2021
48.97%
12Q
12/31/2020
48.76%
13Q
09/30/2020
72.69%
14Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR IMMUNOVANT, INC.
LOADING...